281 related articles for article (PubMed ID: 19617539)
21. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
[TBL] [Abstract][Full Text] [Related]
22. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
Hofmann E; Weibel S; Szalay AA
J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
[TBL] [Abstract][Full Text] [Related]
24. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus.
Haddad D; Chen NG; Zhang Q; Chen CH; Yu YA; Gonzalez L; Carpenter SG; Carson J; Au J; Mittra A; Gonen M; Zanzonico PB; Fong Y; Szalay AA
J Transl Med; 2011 Mar; 9():36. PubMed ID: 21453532
[TBL] [Abstract][Full Text] [Related]
25. Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer.
Weibel S; Hofmann E; Basse-Luesebrink TC; Donat U; Seubert C; Adelfinger M; Gnamlin P; Kober C; Frentzen A; Gentschev I; Jakob PM; Szalay AA
J Transl Med; 2013 May; 11():106. PubMed ID: 23635329
[TBL] [Abstract][Full Text] [Related]
26. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
27. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
[TBL] [Abstract][Full Text] [Related]
28. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
[TBL] [Abstract][Full Text] [Related]
30. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.
Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA
BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309
[TBL] [Abstract][Full Text] [Related]
31. Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
Pencavel TD; Wilkinson MJ; Mansfield DC; Khan AA; Seth R; Karapanagiotou EM; Roulstone V; Aguilar RJ; Chen NG; Szalay AA; Hayes AJ; Harrington KJ
Int J Cancer; 2015 Feb; 136(4):965-76. PubMed ID: 24978211
[TBL] [Abstract][Full Text] [Related]
32. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
33. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.
Jun KH; Gholami S; Song TJ; Au J; Haddad D; Carson J; Chen CH; Mojica K; Zanzonico P; Chen NG; Zhang Q; Szalay A; Fong Y
J Exp Clin Cancer Res; 2014 Jan; 33(1):2. PubMed ID: 24383569
[TBL] [Abstract][Full Text] [Related]
34. Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.
Worschech A; Chen N; Yu YA; Zhang Q; Pos Z; Weibel S; Raab V; Sabatino M; Monaco A; Liu H; Monsurró V; Buller RM; Stroncek DF; Wang E; Szalay AA; Marincola FM
BMC Genomics; 2009 Jul; 10():301. PubMed ID: 19583830
[TBL] [Abstract][Full Text] [Related]
35. Effective oncolytic vaccinia therapy for human sarcomas.
He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
[TBL] [Abstract][Full Text] [Related]
36. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.
Currier MA; Eshun FK; Sholl A; Chernoguz A; Crawford K; Divanovic S; Boon L; Goins WF; Frischer JS; Collins MH; Leddon JL; Baird WH; Haseley A; Streby KA; Wang PY; Hendrickson BW; Brekken RA; Kaur B; Hildeman D; Cripe TP
Mol Ther; 2013 May; 21(5):1014-23. PubMed ID: 23481323
[TBL] [Abstract][Full Text] [Related]
37. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
Frentzen A; Geissinger U; Tsoneva D; Stritzker J
Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
Kloker LD; Berchtold S; Smirnow I; Beil J; Krieg A; Sipos B; Lauer UM
BMC Cancer; 2020 Jul; 20(1):628. PubMed ID: 32631270
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic vaccinia virus therapy of salivary gland carcinoma.
Chernichenko N; Linkov G; Li P; Bakst RL; Chen CH; He S; Yu YA; Chen NG; Szalay AA; Fong Y; Wong RJ
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):173-82. PubMed ID: 23429949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
